These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25465742)

  • 1. miRNA expression is highly sensitive to a drug therapy in Parkinson's disease.
    Alieva AKh; Filatova EV; Karabanov AV; Illarioshkin SN; Limborska SA; Shadrina MI; Slominsky PA
    Parkinsonism Relat Disord; 2015 Jan; 21(1):72-4. PubMed ID: 25465742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and White Blood Cells Show Different miRNA Expression Profiles in Parkinson's Disease.
    Schwienbacher C; Foco L; Picard A; Corradi E; Serafin A; Panzer J; Zanigni S; Blankenburg H; Facheris MF; Giannini G; Falla M; Cortelli P; Pramstaller PP; Hicks AA
    J Mol Neurosci; 2017 Jun; 62(2):244-254. PubMed ID: 28540642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of blood microRNAs associated to Parkinsonĭs disease.
    Margis R; Margis R; Rieder CR
    J Biotechnol; 2011 Mar; 152(3):96-101. PubMed ID: 21295623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression Profiling of Blood microRNAs 885, 361, and 17 in the Patients with the Parkinson's disease: Integrating Interaction Data to Uncover the Possible Triggering Age-Related Mechanisms.
    Behbahanipour M; Peymani M; Salari M; Hashemi MS; Nasr-Esfahani MH; Ghaedi K
    Sci Rep; 2019 Sep; 9(1):13759. PubMed ID: 31551498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-221 serves as a biomarker for Parkinson's disease.
    Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
    Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manganese exposure: Linking down-regulation of miRNA-7 and miRNA-433 with α-synuclein overexpression and risk of idiopathic Parkinson's disease.
    Tarale P; Daiwile AP; Sivanesan S; Stöger R; Bafana A; Naoghare PK; Parmar D; Chakrabarti T; Krishnamurthi K
    Toxicol In Vitro; 2018 Feb; 46():94-101. PubMed ID: 28986288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility?
    Yılmaz ŞG; Geyik S; Neyal AM; Soko ND; Bozkurt H; Dandara C
    OMICS; 2016 Apr; 20(4):224-8. PubMed ID: 27093107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.
    Guled M; Lahti L; Lindholm PM; Salmenkivi K; Bagwan I; Nicholson AG; Knuutila S
    Genes Chromosomes Cancer; 2009 Jul; 48(7):615-23. PubMed ID: 19396864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A miRNA signature of prion induced neurodegeneration.
    Saba R; Goodman CD; Huzarewich RL; Robertson C; Booth SA
    PLoS One; 2008; 3(11):e3652. PubMed ID: 18987751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
    Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
    Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
    Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
    Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analyses identify differentially expressed micrornas in Parkinson's disease.
    Schulz J; Takousis P; Wohlers I; Itua IOG; Dobricic V; Rücker G; Binder H; Middleton L; Ioannidis JPA; Perneczky R; Bertram L; Lill CM
    Ann Neurol; 2019 Jun; 85(6):835-851. PubMed ID: 30990912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.
    Miñones-Moyano E; Porta S; Escaramís G; Rabionet R; Iraola S; Kagerbauer B; Espinosa-Parrilla Y; Ferrer I; Estivill X; Martí E
    Hum Mol Genet; 2011 Aug; 20(15):3067-78. PubMed ID: 21558425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide microRNA expression profiling in idiopathic non-obstructive azoospermia: significant up-regulation of miR-141, miR-429 and miR-7-1-3p.
    Wu W; Qin Y; Li Z; Dong J; Dai J; Lu C; Guo X; Zhao Y; Zhu Y; Zhang W; Hang B; Sha J; Shen H; Xia Y; Hu Z; Wang X
    Hum Reprod; 2013 Jul; 28(7):1827-36. PubMed ID: 23559187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.
    Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG
    Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
    Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
    Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.